Results 101 to 110 of about 8,213 (208)
Detection of coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction
Coxsackievirus B3 is a possible etiologic agent in some forms of myocarditis and idiopathic dilated cardiomyopathy. A method for the detection of coxsackievirus B3 RNA was developed using the polymerase chain reaction based on the amplification of a cDNA
Billingham, M. E. +3 more
core
SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors
Coxsackievirus and related enteroviruses are important human pathogens that cause various diseases with clinical manifestations ranging from trivial flu-like syndromes to dangerous or even fatal diseases such as myocarditis, meningitis and encephalitis ...
Helena Mertlíková-Kaiserová +17 more
core +1 more source
Monthly distribution of coxsackievirus A4 (CA4), B3 (CB3) and B4 (CB4) isolates from January, 2004 to June, 2012 in Chang Gung Memorial Hospital, Taiwan.
Chia-Jie Lee (289823) +7 more
core +1 more source
Perinatal Coxsackievirus B3 Infection with Transient Thrombocytopenia
Coxsackievirus (Cox) B is the second common picornaviruses, after echovirus, detected from children younger than 2 months of age. Neonates who present with Cox B3 infection in the first week are known to have severe illness such as myocarditis or menigoencephalitis. Severity is commonly associated with perinatal vertical transmission. Here, we report a
Kaga, Akimune +6 more
openaire +3 more sources
Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation
Oncolytic viruses represent a paradigm-shifting approach to cancer immunotherapy, functioning as in situ vaccines that convert immunologically “cold” tumors into “hot” tumors through induction of immunogenic cell death (ICD). Despite the clinical success
Hiroyuki Inoue
doaj +1 more source
Adenosine triphosphate is an allosteric inhibitor of coxsackievirus B3 3Dpol [PDF]
2016 Spring.Includes bibliographical references.Picornaviruses pose a significant threat to human and animal health, but at present there are no drugs to prevent or treat picornaviral infections. However, intensive study of the picornaviral lifecycle has
Cohen, Robert, committee member +3 more
core
Background: Hand, foot and mouth disease (HFMD) is usually caused by EVA71 and CVA16 except for a few cases that are caused by non-EVA71 non-CAV16 enteroviruses.
Xuemin Fu +7 more
doaj +1 more source
IL-9 inhibits viral replication in Coxsackievirus B3-induced myocarditis
Myocardial injuries in viral myocarditis (VMC) are caused by viral infection and related autoimmune disorders. Recent studies suggest that IL-9 mediated both antimicrobial immune and autoimmune responses in addition to allergic diseases.
Miao Yu +6 more
doaj +1 more source
Study on the inhibitory effect of geniposide on coxsackievirus and its mechanism
BackgroundCoxsackievirus infection can cause various diseases such as myocarditis and encephalitis, posing a serious threat to human health. However, there are currently no specific therapeutic drugs or effective vaccines for Coxsackievirus infection, so
Jianbo Xia, Zuliang Shi, Mengxin Shen
doaj +1 more source
Gegenstand dieser Promotionsarbeit waren die zellulären Ereignisse im Verlauf einer Infektion mit Coxsackievirus B3. Das Capsidprotein VP2 von Coxsackievirus B3 interagiert mit einem bis dahin wenig erforschten Protein.
Nestler, Matthias
core

